Skip to main content

Table 2 Women’s organisational preferences and adoption of health behaviours after risk feedback

From: Women’s health behaviour change after receiving breast cancer risk estimates with tailored screening and prevention recommendations

  

Self-reported breast cancer risk

All women

N = 325

Low

N = 60

Average

N = 125

Moderate

N = 80

High

N = 60

Risk result in letter, n acceptable (%)a

251

(77.2)

53

(88.3)

104

(83.2)

61

(76.3)

33

(55.0)

Need for consultation, n yes (%)

99

(30.5)

2

(3.3)

24

(19.2)

28

(35.0)

45

(75.0)

Preferred risk counsellor, n (%)b

 General practitioner

49

(49.5)

1

(50.0)

14

(40.0)

11

(30.6)

23

(30.3)

 Oncologist

42

(42.4)

1

(50.0)

11

(31.4)

11

(30.6)

19

(25.0)

 Geneticist

37

(37.4)

–

–

2

(5.7)

10

(27.7)

25

(32.9)

 Nurse

21

(21.2)

–

–

8

(22.9)

4

(11.1)

9

(11.8)

 Radiologist

–

–

–

–

–

–

–

–

–

–

 Radiographer

–

–

–

–

–

–

–

–

–

–

Use website, n yes (%)

243

(74.8)

41

(68.3)

97

(77.6)

59

(73.8)

46

(76.7)

Screening intent, n yes (%)c

308

(94.8)

54

(90.0)

123

(98.4)

78

(97.5)

53

(88.3)

Supplemental mammography intent, n yes (%)d

47

(22.9)

n/a

16

(12.8)

31

(38.8)

n/a

Preferred screening interval low risk

 3-year

  

34

(56.7)

      

 4-year

  

20

(33.3)

      

 5-year

  

4

(6.7)

      

 Don’t know

  

2

(3.3)

      

Preferred screening interval high risk

 6-month

        

5

(8.3)

 1-year

        

34

(56.7)

 18-month

        

16

(26.6)

 2-year

        

3

(5.0)

 3-year

        

1

(1.7)

 Don’t know

        

1

(1.7)

 

All women

N = 325

Low risk

N = 60

Average risk

N = 125

Moderate risk

N = 80

High risk

N = 60

Increased breast self-exam, n yes (%)

124

(38.2)

12

(20.0)

36

(28.8)

39

(48.8)

37

(61.7)

Changed diet (%)

 Yes

77

(23.7)

7

(11.7)

20

(16.0)

23

(28.7)

27

(45.0)

 No

69

(21.2)

10

(16.7)

37

(29.6)

12

(15.0)

10

(16.7)

 No, not required

179

(55.1)

43

(71.6)

68

(54.4)

45

(56.3)

23

(38.3)

Changed exercise habits, n (%)

 Yes

86

(26.5)

16

(26.7)

28

(22.4)

16

(20.0)

18

(30.0)

 No

102

(31.4)

15

(25.0)

48

(38.4)

23

(28.8)

16

(26.7)

 No, not required

137

(42.1)

29

(48.3)

49

(39.2)

41

(51.2)

26

(43.3)

Changed alcohol intake, n (%)

 Yes

65

(20.0)

12

(20.0)

22

(17.6)

17

(21.2)

14

(23.3)

 No

107

(34.8)

17

(28.3)

47

(37.6)

23

(28.8)

20

(33.3)

 No, not required

153

(47.2)

31

(51.7)

56

(44.8)

40

(50.0)

26

(43.4)

Started medication, n yes (%)e

46

(50.0)

n/a

 

n/a

 

13

(31.7)

33

(66.0)

Willing to consider medication, n yes (%)f

16

(33.3)

n/a

 

n/a

 

13

(33.3)

3

(33.3)

Tamoxifen preference, n (%)

 Pill

73

(52.1)

n/a

 

n/a

 

32

(40.0)

41

(68.4)

 Cream

22

(15.7)

n/a

 

n/a

 

17

(21.3)

5

(8.3)

 No preference

9

(6.4)

n/a

 

n/a

 

8

(10.0)

1

(1.7)

 Neither

28

(20.1)

n/a

 

n/a

 

17

(21.3)

11

(18.3)

 Don’t know

8

(5.7)

n/a

 

n/a

 

6

(7.4)

2

(3.3)

  1. a High-risk women did not receive their risk result in a letter, but were asked about a hypothetical scenario; b Percentages based on the number of women who perceived a need for a consultation, women could mark multiple options; c Based on stratified interval displayed in Fig. 1; d Based on a 4-year screening interval for low-risk women, and a 3-year screening interval for average and moderate risk women, e Based on number of women who indicated that tamoxifen was discussed with them for the PROCAS study; f Based on number of women who were eligible for preventative medication but indicated that it was not discussed with them for the PROCAS study
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us